SCHOTT Pharma AG & Co KgaA
F:1SXP
Income Statement
Earnings Waterfall
SCHOTT Pharma AG & Co KgaA
Income Statement
SCHOTT Pharma AG & Co KgaA
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
3
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
|
| Revenue |
899
N/A
|
1 131
+26%
|
1 365
+21%
|
949
-31%
|
957
+1%
|
955
0%
|
973
+2%
|
976
+0%
|
986
+1%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(582)
|
(731)
|
(886)
|
(625)
|
(634)
|
(639)
|
(653)
|
(646)
|
(654)
|
|
| Gross Profit |
316
N/A
|
400
+26%
|
479
+20%
|
324
-32%
|
323
0%
|
315
-2%
|
320
+1%
|
329
+3%
|
332
+1%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(145)
|
(172)
|
(226)
|
(155)
|
(132)
|
(155)
|
(136)
|
(139)
|
(146)
|
|
| Selling, General & Administrative |
(126)
|
(154)
|
(185)
|
(126)
|
(125)
|
(126)
|
(127)
|
(128)
|
(129)
|
|
| Research & Development |
(27)
|
(33)
|
(40)
|
(27)
|
(24)
|
(25)
|
(25)
|
(27)
|
(28)
|
|
| Other Operating Expenses |
7
|
15
|
(1)
|
(3)
|
18
|
(5)
|
17
|
16
|
12
|
|
| Operating Income |
171
N/A
|
228
+33%
|
254
+11%
|
169
-33%
|
191
+12%
|
160
-16%
|
184
+15%
|
190
+3%
|
187
-2%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
17
|
11
|
12
|
5
|
(1)
|
5
|
4
|
2
|
9
|
|
| Non-Reccuring Items |
7
|
8
|
8
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(9)
|
(5)
|
(5)
|
(3)
|
(7)
|
(1)
|
(1)
|
(0)
|
(9)
|
|
| Pre-Tax Income |
186
N/A
|
241
+30%
|
268
+11%
|
174
-35%
|
184
+6%
|
164
-11%
|
188
+14%
|
192
+2%
|
188
-2%
|
|
| Net Income | ||||||||||
| Tax Provision |
(34)
|
(45)
|
(46)
|
(23)
|
(34)
|
(30)
|
(40)
|
(45)
|
(41)
|
|
| Income from Continuing Operations |
152
|
196
|
222
|
150
|
150
|
134
|
148
|
147
|
147
|
|
| Income to Minority Interest |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Net Income (Common) |
152
N/A
|
196
+29%
|
221
+13%
|
150
-32%
|
150
0%
|
134
-11%
|
147
+10%
|
147
0%
|
146
0%
|
|
| EPS (Diluted) |
1.01
N/A
|
1.3
+29%
|
1.47
+13%
|
1
-32%
|
0.99
-1%
|
0.89
-10%
|
0.98
+10%
|
0.97
-1%
|
0.97
N/A
|
|